| Product NDC: | 21695-520 |
| Proprietary Name: | Piroxicam |
| Non Proprietary Name: | Piroxicam |
| Active Ingredient(s): | 10 mg/1 & nbsp; Piroxicam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-520 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074131 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091112 |
| Package NDC: | 21695-520-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (21695-520-60) |
| NDC Code | 21695-520-60 |
| Proprietary Name | Piroxicam |
| Package Description | 60 CAPSULE in 1 BOTTLE (21695-520-60) |
| Product NDC | 21695-520 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piroxicam |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20091112 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | PIROXICAM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |